Keith L Knutson, PhD

  • 11084 Citations
  • 49 Scopus h-Index
1993 …2020
If you made any changes in Pure, your changes will be visible here soon.

Projects 2004 2020

Active

Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer

Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Galanis, E., Knutson, K. L., Hartmann, L. C., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E., Keeney, G., Shridhar, V., Cliby, W. A., Goode, E. L., Peng, K., Hartmann, L. C. & Lingle, W. L.

National Institutes of Health

10/1/088/31/20

Project: Research project

Ovarian Neoplasms
alvocidib
Registries
Research
Translational Medical Research
Finished

Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab

Perez, E. A., Clynes, R. & Knutson, K. L.

National Institutes of Health

1/1/1112/31/16

Project: Research project

Immunity
Drug Therapy
Breast Neoplasms
Antibody Formation
Trastuzumab
Folate Receptor 1
Folic Acid
Ovarian Neoplasms
Antibodies
Serum
Immunity
Histocompatibility Antigens Class I
Breast Neoplasms
Peptides
Neoplasm Antigens
Helper-Inducer T-Lymphocytes
Cytotoxic T-Lymphocytes
Neoplasms
T-Lymphocytes
Th2 Cells
Neoplasm Antigens
Epitopes
Antigens
Immunization
Subunit Vaccines